X antigen family member 1 (17-32)

X antigen family member 1 (17-32) is a synthetic peptide fragment derived from the X antigen family member 1 protein, representing amino acid residues 17 through 32 of the native sequence. As a defined peptide segment, it holds particular significance in immunology, molecular biology, and peptide-based assay development due to its specificity and relevance to the parent protein's functional domains. Researchers utilize such peptide fragments to dissect protein function, study antigenic determinants, and explore protein-protein interactions in a controlled experimental context. The defined sequence of this peptide makes it a valuable tool for probing the biological roles and molecular mechanisms associated with the X antigen family, facilitating targeted investigations in diverse biochemical fields.

Epitope mapping: In immunological research, the 17-32 peptide fragment of X antigen family member 1 serves as a precise reagent for identifying linear B-cell or T-cell epitopes. By providing a well-characterized segment of the parent protein, the peptide allows researchers to assess antibody binding specificity, map immunodominant regions, and evaluate immune recognition patterns. Such studies are crucial for understanding immune responses to the X antigen family and can inform the design of peptide-based probes or reagents for downstream immunoassays.

Antibody production and validation: The defined sequence of this peptide fragment enables its use as an immunogen or as a quality control standard in the generation and validation of antibodies targeting X antigen family member 1. When conjugated to carrier proteins, the peptide can elicit specific antibody responses in experimental animals or be employed in affinity purification protocols. In addition, it provides a robust positive control for testing antibody specificity in applications such as ELISA, western blotting, or immunohistochemistry, ensuring accurate detection and minimizing cross-reactivity.

Protein-protein interaction studies: The synthetic peptide corresponding to residues 17-32 can be utilized to investigate binding interactions between X antigen family member 1 and other biomolecules. By serving as a molecular probe, it enables the dissection of interaction interfaces and the identification of sequence motifs critical for partner recognition. Such studies are instrumental in elucidating the functional networks and signaling pathways in which the parent protein participates, advancing our understanding of its cellular roles.

Peptide functional analysis: Researchers can employ the 17-32 fragment in functional assays to explore the biological activity associated with this specific region of X antigen family member 1. By introducing the peptide into cell-based or in vitro systems, it is possible to assess its capacity to modulate signaling events, inhibit native protein function, or act as a competitive substrate. These experimental approaches provide insights into the mechanistic contributions of discrete protein segments, supporting targeted hypothesis testing and mechanistic elucidation.

Assay development and optimization: The availability of a synthetic peptide with a defined sequence supports the development and refinement of analytical assays, including enzyme-linked immunosorbent assays (ELISA), mass spectrometry-based quantification, and peptide competition studies. The fragment can serve as a calibration standard, assay control, or competitive inhibitor, enhancing assay specificity, sensitivity, and reproducibility. By integrating this peptide into assay workflows, laboratories can achieve more reliable quantification and detection of X antigen family member 1-related analytes in complex biological samples.

1. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

4. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry